MHRA: Drug Safety Update (Feb 21): https://www.gov.uk/drug-safety-update/covid-19-vaccines-and-medicines-updates-for-february-2021

MHRA: Drug Safety Update (Feb 21): Medicines in pregnancy and breastfeeding: new initiative for consistent guidance; report on optimising data for medicines used during pregnancy

MHRA: Drug Safety Update (Feb 21): Alkindi (hydrocortisone granules): risk of acute adrenal insufficiency in children when switching from hydrocortisone tablet formulations to granules

MHRA: Drug Safety Update (Feb 21): Pregabalin (Lyrica): reports of severe respiratory depression

MHRA: Drug Safety Update (Feb 21): Ulipristal acetate 5mg (Esmya): further restrictions due to risk of serious liver injury

MHRA: Drug Safety Update(Jan 21): Aminoglycosides (gentamicin, amikacin, tobramycin, and neomycin): increased risk of deafness in patients with mitochondrial mutations